Sarasin & Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Sarasin & Partners's MDT Position: Q4 2020 in Review
Sarasin & Partners sold out of Medtronic (MDT) in Q4 2020, closing a stake of 1,621,724 shares — an estimated $169M sold.
Sarasin & Partners first reported a position in MDT in Q1 2014 and held it in 19 quarters. The position peaked at $169M in Q3 2020. 1,958 funds tracked by Wall St. Rank hold MDT as of Q4 2020.
- Sarasin & Partners reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
- Sarasin & Partners sold 1,621,724 Medtronic shares in Q4 2020, an estimated $169M.
- Sarasin & Partners first reported a position in Medtronic in Q1 2014 and held it in 19 quarters.
- Sarasin & Partners's Medtronic position peaked at $169M in Q3 2020.
- 1,958 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.
Based on Sarasin & Partners's 13F filing for Q4 2020, filed 19 Jan 2021.